In the last trading session, 17.74 million Entero Therapeutics Inc (NASDAQ:ENTO) shares changed hands as the company’s beta touched 0.76. With the company’s per share price at $0.51 changed hands at $0.07 or 16.48% during last session, the market valuation stood at $2.43M. ENTO’s last price was a discount, traded about -705.88% off its 52-week high of $4.11. The share price had its 52-week low at $0.19, which suggests the last value was 62.75% up since then. When we look at Entero Therapeutics Inc’s average trading volume, we note the 10-day average is 2.61 million shares, with the 3-month average coming to 357.44K.
Entero Therapeutics Inc (NASDAQ:ENTO) trade information
Instantly ENTO was in green as seen at the end of in last trading. With action 5.95%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -18.17%, with the 5-day performance at 5.95% in the green. However, in the 30-day time frame, Entero Therapeutics Inc (NASDAQ:ENTO) is -9.11% down. Looking at the short shares, we see there were 0.14 million shares sold at short interest cover period of 0.26 days.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 82.03%.
ENTO Dividends
Entero Therapeutics Inc is expected to release its next quarterly earnings report on 2025-Mar-31.
Entero Therapeutics Inc (NASDAQ:ENTO)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 3.75% of Entero Therapeutics Inc shares while 1.51% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 1.57%.
Among Mutual Funds, the top two as of Feb 28, 2025 were Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . With 15.05 shares estimated at $7662.0 under it, the former controlled 0.32% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held about 0.10% of the shares, roughly 4.54 shares worth around $2308.0.
